Physician profile
Emily Hester
NPI 1790492056
$948.06
in general payments reported to CMS, 2019-2025
15 companies · $189 in 2025
The $189 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $182 · 2023: $255 · 2024: $322 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $766.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $255.88 | 2023-2025 | Rybelsus, Ozempic |
| Medtronic, INC. | $212.45 | 2022-2025 | Kyphon Express II Kyphopak Tray, Inceptiv |
| Abbvie INC. | $174.80 | 2023-2025 | |
| Xeris Pharmaceuticals, INC. | $52.76 | 2024-2025 | Gvoke Hypopen |
| Bayer Healthcare Pharmaceuticals INC. | $46.72 | 2022-2024 | |
| Lilly USA, LLC | $28.27 | 2023-2024 | Mounjaro, Jardiance, Emgality |
| Nevro Corp. | $27.22 | 2023 | Senza |
| Globus Medical, INC. | $27.03 | 2025 | Senza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.02 | 2024 | Jardiance |
| Exact Sciences Corporation | $19.50 | 2023 | Cologuard Collection Kit |
| Insulet Corporation | $17.12 | 2023 | Omnipod |
| Abbott Laboratories | $16.45 | 2024 | Freestyle Libre 3 |
| Otsuka America Pharmaceutical, INC. | $14.73 | 2025 | Rexulti |
| Boston Scientific Corporation | $14.58 | 2025 | Bodyguardian |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $13.53 | 2024 | Caplyta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Hester listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.